Şenol Demir, Ceren Alavanda, Gözde Yeşil, Ayça Dilruba Aslanger, Esra Arslan Ateş
Introduction: Myhre syndrome (MS; OMIM #139210) is a rare connective tissue disorder presenting with cardiovascular, respiratory, gastrointestinal, and skeletal system findings. Fewer than 100 patients were reported until recently, and all molecularly confirmed cases had de novo heterozygous gain-of-function mutations in the gene. Dysregulation of the TGF-beta signaling pathway leads to axial and appendicular skeleton, connective tissue, cardiovascular system, and central nervous system abnormalities.
Case Presentation: Two siblings, 12 and 9 years old, were referred to us because of intellectual disability, neurodevelopmental delay, and dysmorphic facial features. Physical examination revealed hypertelorism, strabismus, small mouth, prognathism, short neck, stiff skin, and brachydactyly.
Discussion: With a clinical diagnosis of MS, the gene was analyzed via Sanger sequencing, and a heterozygous c.1486C>T (p.Arg496Cys) pathogenic variation was detected in both of the siblings. The segregation analysis revealed that the mutation was inherited from the father who displayed a milder phenotype. Among the 90 patients in the literature, one family was reported in which two siblings carried the same variation (p.Arg496Cys), inherited from the severely affected mother. We are reporting the second family which has three affected family members, a father and two children. We report this study to remind the clinicians to be aware of the parental transmission of variations and also evaluate the parents of the Myhre cases.
Mol Syndromol. 2020 Jan;10(6):339-343
[PMID:
32021609]
Cytokine Growth Factor Rev. 2017 Dec;38:49-58
[PMID:
28967471]
Orphanet J Rare Dis. 2022 Jul 30;17(1):304
[PMID:
35907855]
Clin Dysmorphol. 2019 Jul;28(3):145-150
[PMID:
30921096]
Am J Med Genet A. 2020 Feb;182(2):328-337
[PMID:
31837202]
Clin Genet. 2014 Jun;85(6):503-13
[PMID:
24580733]
Pediatr Int. 2017 Nov;59(11):1205-1206
[PMID:
29359479]
Am J Med Genet A. 2022 May;188(5):1384-1395
[PMID:
35025139]
Eur J Pediatr. 2016 Oct;175(10):1307-15
[PMID:
27562837]
Am J Med Genet. 2001 Oct 1;103(2):163-5
[PMID:
11568925]
Eur J Hum Genet. 2014 Nov;22(11):1272-7
[PMID:
24424121]
Am J Med Genet C Semin Med Genet. 2012 Aug 15;160C(3):145-53
[PMID:
22791552]
Clin Dysmorphol. 2018 Jan;27(1):12-14
[PMID:
28562390]
Oncotarget. 2016 Sep 20;7(38):61262-61272
[PMID:
27542208]
Am J Med Genet A. 2019 Dec;179(12):2494-2499
[PMID:
31595668]
Am J Med Genet A. 2014 Jul;164A(7):1835-40
[PMID:
24715504]
Am J Respir Crit Care Med. 2020 Mar 15;201(6):731-732
[PMID:
31539271]
Am J Med Genet A. 2016 Oct;170(10):2617-31
[PMID:
27302097]
Am J Otolaryngol. 2015 Sep-Oct;36(5):636-41
[PMID:
25940662]
Nat Genet. 2011 Dec 11;44(1):85-8
[PMID:
22158539]
Stem Cell Res Ther. 2020 Jan 29;11(1):41
[PMID:
31996252]
Clin Chim Acta. 2020 Jan;500:128-134
[PMID:
31654632]
Am J Hum Genet. 2012 Jan 13;90(1):161-9
[PMID:
22243968]
Clin Genet. 1981 Jul;20(1):1-5
[PMID:
7296942]
Am J Med Genet A. 2018 Feb;176(2):426-430
[PMID:
29230941]